![Sana Alajmovic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Sana Alajmovic was the founder of Sigrid Therapeutics AB, founded in 2014, and held the title of Chief Executive Officer & Director.
Ms. Alajmovic currently holds the position of Chief Executive Officer at Enzymatica AB, starting in 2026.
Postes actifs de Sana Alajmovic
| Sociétés | Poste | Début |
|---|---|---|
| ENZYMATICA AB | Directeur Général | 01/02/2026 |
Anciens postes connus de Sana Alajmovic
| Sociétés | Poste | Fin |
|---|---|---|
Sigrid Therapeutics AB
 Sigrid Therapeutics AB Pharmaceuticals: OtherHealth Technology Manufactures and sells dietary supplement products for blood sugar & weight management, glucose stabilizer and foods | Fondateur | 31/01/2026 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Enzymatica AB
 Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Pharmaceuticals: OtherHealth Technology Manufactures and sells dietary supplement products for blood sugar & weight management, glucose stabilizer and foods | Health Technology |
